Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11603377 MTORC1 modulators and uses thereof

Patent 11603377 was granted and assigned to Aeovian Pharmaceuticals on March, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 19 Jul, 2023
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jul, 2023
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11702429 mTORC modulators and uses thereof
0
Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 24 Apr, 2023
Edits on 6 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 6 Apr, 2023
Edits on 15 Mar, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 15 Mar, 2023
Edits made to:
Infobox (+14 properties)
‌

 US Patent 11603377 MTORC1 modulators and uses thereof

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Aeovian Pharmaceuticals, Inc.
0
Current Assignee
‌
Aeovian Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116033770
Date of Patent
March 14, 2023
0
Patent Application Number
178322400
Date Filed
June 3, 2022
0
Patent Citations
‌
US Patent 11230557 mTORC modulators and uses thereof
0
‌
US Patent 10683308 Rapamycin analogs and uses thereof
0
‌
US Patent 11021492 mTORC modulators and uses thereof
0
Patent Primary Examiner
‌
Jeffrey H Murray
0
CPC Code
‌
C07D 498/18
0
‌
A61K 31/436
0

Find more entities like US Patent 11603377 MTORC1 modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo